Efficacy of dupilumab in atopic comorbidities associated with moderate-to-severe adult atopic dermatitis.
Eustachio NettisVincenzo PatellaCarla LombardoAikaterini DetorakiLuigi MacchiaElisabetta Di LeoMonica CarbonaraGiorgio W CanonicaLaura BonzanoPublished in: Allergy (2020)
These results support the benefits of dupilumab for adult patients with PAR and/or PAA associated with msAD.